|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00954 CHANGMAO BIO
Nominal 
0.295 0.000 (0.000%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 584,794 | -8.207% | 637,078 | 730,034 | 547,976 | 444,106 |
| Cost of Sales | (568,017) | -7.076% | (611,269) | (549,203) | (509,296) | (348,657) |
| Gross Profit | 16,777 | -34.996% | 25,809 | 180,831 | 38,680 | 95,449 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (205) | 12.022% | (183) | 136 | (28) | 120 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (67,582) | 15.367% | (58,580) | 87,644 | 84,409 | 17,152 | |
| Taxation | (669) | -97.605% | (27,938) | (6,286) | (26,202) | (409) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 8 | -98.265% | 461 | 65 | 111 | 84 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (68,243) | -20.700% | (86,057) | 81,423 | 58,318 | 16,827 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 10,514 | 60.961% | 6,532 | 1,729 | 1,415 | (153) |
| Depreciation & Amortisation | 45,616 | 6.717% | 42,745 | 32,202 | 29,214 | 32,783 |
| Directors' Emoluments | 1,987 | 0.404% | 1,979 | 6,615 | 1,831 | 1,791 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -12.900 | -20.370% | -16.200 | 15.400 | 11.000 | 3.200 |
| DPS (cts) | 0.000 | -- | 0.000 | 7.700 | 0.000 | 2.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | 50.000% | -- | 62.500% |
| Cash flow per share ($) | (0.061) | -- | (0.004) | 0.037 | (0.013) | 0.111 |
| NBV per share ($) | 1.101 | -- | 1.230 | 1.470 | 1.316 | 1.226 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -25,790 |
| %Change | 37.283% |
| EPS / (LPS) | RMB -0.049 |
| NBV Per Share (¥) | RMB 1.053 |